Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Debt Ratio: 2020-2024

Historic Debt Ratio for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to 0.54.

  • Oncology Institute's Debt Ratio fell 884.24% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year decrease of 258.48%. This contributed to the annual value of 0.54 for FY2024, which is 2994.34% up from last year.
  • Per Oncology Institute's latest filing, its Debt Ratio stood at 0.54 for FY2024, which was up 2994.34% from 0.41 recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Debt Ratio peaked at 0.54 during FY2024, and registered a low of 0.0 during FY2021.
  • Over the past 5 years, Oncology Institute's median Debt Ratio value was 0.31 (recorded in 2022), while the average stood at 0.29.
  • As far as peak fluctuations go, Oncology Institute's Debt Ratio crashed by 9950.47% in 2021, and later soared by 3415197.89% in 2022.
  • Annual analysis of 5 years shows Oncology Institute's Debt Ratio stood at 0.18 in 2020, then crashed by 99.5% to 0.0 in 2021, then skyrocketed by 34151.98% to 0.31 in 2022, then skyrocketed by 34.68% to 0.41 in 2023, then grew by 29.94% to 0.54 in 2024.
  • Its Debt Ratio stands at 0.54 for FY2024, versus 0.41 for FY2023 and 0.31 for FY2022.